Search results
WBEZ and Bookends and Beginnings Present: On Call - An Evening w Dr. Anthony Fauci and Sasha-Ann...
Chicago Sun-Times· 6 days agoWBEZ and Bookends and Beginnings are proud to present Dr. Anthony Fauci on Wednesday, June 26 at...
Risk-Targeted Preventive TB Treatment Works, Particularly With Infection Testing
MedPage Today· 6 days agoLarge real-world analysis homes in on the best strategies in high- and low-burden settings
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 1 day agoAll three first-in-class modifier gene therapy product candidates currently in the clinic with OCU400 Phase 3 in progressOCU400 on track to meet 2026 Biologics License Application (BLA) and Market Authorization Application (MAA) approval targets
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 5 days agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 5 days agoUT Health San Antonio to lead $11 million, NIH-funded study of a first-ever oral chlamydia vaccine PR Newswire SAN ANTONIO, May 9, 2024 The University of Texas Health Science Center at San Antonio ...
UT Health San Antonio to lead $11 million, NIH-funded study of a first-ever oral chlamydia vaccine
PRWeb· 6 days ago/PRNewswire-PRWeb/ -- A research team led by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been awarded...